| Schedule of liabilities to be presented on balance sheet at fair value |
| Schedule of liabilities
to be presented on balance sheet at fair value | |
| |
| |
| |
|
| | |
Fair Value | |
Fair Value Measurements at |
| | |
As of | |
December 31, 2024 |
| Description | |
December 31, 2024 | |
Using Fair Value Hierarchy |
| | |
| |
Level 1 | |
Level 2 | |
Level 3 |
| Conversion feature on convertible notes | | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | |
| | |
Fair Value | |
Fair Value Measurements at |
| | |
As of | |
June 30, 2025 |
| Description | |
June 30, 2025 | |
Using Fair Value Hierarchy |
| | |
| |
Level 1 | |
Level 2 | |
Level 3 |
| Conversion feature on convertible notes | | |
$ | — | | |
$ | — | | |
$ | — | | |
$ | — | |
|
| Schedule of potentially- dilutive shares |
| Schedule of potentially- dilutive shares | |
| | | |
| | |
| | |
June 30,
2025 | |
December 31,
2024 |
| Basic outstanding common stock | |
| 18,492,870,775 | | |
| 16,813,229,180 | |
| Series B preferred stock | |
| 150,000 | | |
| 150,000 | |
| Series C preferred stock | |
| 385,000 | | |
| 385,000 | |
| Series H preferred stock | |
| 1,000,000 | | |
| 1,000,000 | |
| Series I preferred stock | |
| 10,000,000,000 | | |
| 10,000,000,000 | |
| Warrants | |
| 400 | | |
| 400 | |
| Convertible notes | |
| 609,003,599,616 | | |
| 579,341,100,593 | |
| Total | |
| 637,498,005,791 | | |
| 606,155,865,173 | |
|